Emi Minejima

1.1k total citations · 1 hit paper
26 papers, 766 citations indexed

About

Emi Minejima is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Emi Minejima has authored 26 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 11 papers in Epidemiology and 10 papers in Clinical Biochemistry. Recurrent topics in Emi Minejima's work include Antimicrobial Resistance in Staphylococcus (12 papers), Bacterial Identification and Susceptibility Testing (10 papers) and Streptococcal Infections and Treatments (7 papers). Emi Minejima is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (12 papers), Bacterial Identification and Susceptibility Testing (10 papers) and Streptococcal Infections and Treatments (7 papers). Emi Minejima collaborates with scholars based in United States and Saudi Arabia. Emi Minejima's co-authors include Annie Wong‐Beringer, Mimi Lou, Michael Neely, David S. Bayard, Brenda Jones, Paul Nieberg, Michael Van Guilder, Walter M. Yamada, Alan Schumitzky and Rosemary C. She and has published in prestigious journals such as Circulation, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Emi Minejima

26 papers receiving 749 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prospective Trial on the Use of Trough Concentration versus Area under the Curve To Determine Therapeutic Vancomycin Dosing

2017 268 citations Michael Neely, Emi Minejima et al. Antimicrobial Agents and Chemotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emi Minejima United States	13	478	334	324	245	128	26	766
Holly Maples United States	13	841 1.8×	408 1.2×	780 2.4×	323 1.3×	153 1.2×	20	1.4k
Kenneth Klinker United States	19	575 1.2×	369 1.1×	436 1.3×	494 2.0×	113 0.9×	42	1.1k
Levita Hidayat United States	11	737 1.5×	575 1.7×	302 0.9×	245 1.0×	190 1.5×	18	1.2k
Rachel M. Kenney United States	15	220 0.5×	172 0.5×	153 0.5×	230 0.9×	49 0.4×	74	805
Donald Hsu United States	11	868 1.8×	579 1.7×	352 1.1×	324 1.3×	194 1.5×	16	1.2k
Lina Meng United States	13	178 0.4×	133 0.4×	204 0.6×	145 0.6×	66 0.5×	24	490
Yazdan Mirzanejad Canada	13	183 0.4×	126 0.4×	174 0.5×	356 1.5×	71 0.6×	22	753
Friederike Traunmüller Austria	19	263 0.6×	123 0.4×	547 1.7×	311 1.3×	71 0.6×	32	891
Lala M. Dunbar United States	16	396 0.8×	254 0.8×	258 0.8×	465 1.9×	150 1.2×	22	1.1k
Denis Bugnon France	16	290 0.6×	179 0.5×	395 1.2×	351 1.4×	52 0.4×	32	816

Countries citing papers authored by Emi Minejima

Since Specialization

Citations

This map shows the geographic impact of Emi Minejima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emi Minejima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emi Minejima more than expected).

Fields of papers citing papers by Emi Minejima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emi Minejima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emi Minejima. The network helps show where Emi Minejima may publish in the future.

Co-authorship network of co-authors of Emi Minejima

This figure shows the co-authorship network connecting the top 25 collaborators of Emi Minejima. A scholar is included among the top collaborators of Emi Minejima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emi Minejima. Emi Minejima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wald‐Dickler, Noah, Catherine P. Canamar, Kusha Davar, et al.. (2023). Real-World Application of Oral Therapy for Infective Endocarditis: A Multicenter, Retrospective, Cohort Study. Clinical Infectious Diseases. 77(5). 672–679. 33 indexed citations

Lou, Mimi, et al.. (2023). Machine learning to identify risk factors associated with the development of ventilated hospital-acquired pneumonia and mortality: implications for antibiotic therapy selection. Frontiers in Medicine. 10. 1268488–1268488. 7 indexed citations

Chambliss, Allison B, Khushbu Patel, Jessica M Colón-Franco, et al.. (2023). AACC Guidance Document on the Clinical Use of Procalcitonin. The Journal of Applied Laboratory Medicine. 8(3). 598–634. 15 indexed citations

Lou, Mimi, et al.. (2023). Prognostic significance of early platelet dynamics in Staphylococcus aureus bacteremia. BMC Infectious Diseases. 23(1). 82–82. 7 indexed citations

Domínguez, Fernándo, Kusha Davar, Noah Wald‐Dickler, et al.. (2022). How to change the course: practical aspects of implementing shorter is better. Clinical Microbiology and Infection. 29(11). 1402–1406. 4 indexed citations

Ng, Tien M. H., et al.. (2022). Acute Bacterial Infections and Longitudinal Risk of Readmissions and Mortality in Patients Hospitalized with Heart Failure. Journal of Clinical Medicine. 11(3). 740–740. 1 indexed citations

Minejima, Emi, et al.. (2022). Evaluation of step-down oral antibiotic therapy for uncomplicated streptococcal bloodstream infections on clinical outcomes. Therapeutic Advances in Infectious Disease. 9. 1998308064–1998308064. 16 indexed citations

Minejima, Emi, et al.. (2021). Cytokine measurements add value to clinical variables in predicting outcomes for Staphylococcus aureus bacteremia. BMC Infectious Diseases. 21(1). 317–317. 10 indexed citations

Porter, Edith, et al.. (2021). Increased Risk of Thrombocytopenia and Death in Patients with Bacteremia Caused by High Alpha Toxin-Producing Methicillin-Resistant Staphylococcus aureus. Toxins. 13(10). 726–726. 8 indexed citations

10.

Bolaris, Michael, et al.. (2020). Cost–benefit analysis comparing trough, two-level AUC and Bayesian AUC dosing for vancomycin. Clinical Microbiology and Infection. 27(9). 1346.e1–1346.e7. 30 indexed citations

11.

Minejima, Emi, Melissa Mert, Wendy J. Mack, et al.. (2019). Defining the Breakpoint Duration of Staphylococcus aureus Bacteremia Predictive of Poor Outcomes. Clinical Infectious Diseases. 70(4). 566–573. 97 indexed citations

12.

Minejima, Emi, et al.. (2019). Utility of qSOFA score in identifying patients at risk for poor outcome in Staphylococcus aureus bacteremia. BMC Infectious Diseases. 19(1). 149–149. 14 indexed citations

13.

Van, Tam T., et al.. (2019). Don't Get Wound Up: Revised Fluoroquinolone Breakpoints for Enterobacteriaceae and Pseudomonas aeruginosa. Journal of Clinical Microbiology. 57(7). 27 indexed citations

14.

Joyce, Geoffrey, et al.. (2018). Abstract 10876: Nosocomial Infections Are Associated With Increased Hospital Readmissions, Mortality, and Cost in Patients Hospitalized With Heart Failure. Circulation. 1 indexed citations

15.

Yadav, Kabir, Eriko Masuda, Emi Minejima, & Brad Spellberg. (2018). Expected Practice as a Novel Antibiotic Stewardship Intervention. Open Forum Infectious Diseases. 6(1). ofy319–ofy319. 10 indexed citations

16.

Kim, Tae Hun, Emi Minejima, Brad Spellberg, et al.. (2017). Evaluation of the FilmArray Meningitis/Encephalitis Molecular Panel in a Tertiary Care Public County Hospital. Open Forum Infectious Diseases. 4(suppl_1). S596–S596. 1 indexed citations

17.

Minejima, Emi & Annie Wong‐Beringer. (2016). Implementation of rapid diagnostics with antimicrobial stewardship. Expert Review of Anti-infective Therapy. 14(11). 1065–1075. 31 indexed citations

18.

Minejima, Emi, Rosemary C. She, Wendy J. Mack, et al.. (2015). A Dysregulated Balance of Proinflammatory and Anti-Inflammatory Host Cytokine Response Early During Therapy Predicts Persistence and Mortality in Staphylococcus aureus Bacteremia*. Critical Care Medicine. 44(4). 671–679. 53 indexed citations

19.

Minejima, Emi, Mimi Lou, Paul Nieberg, & Annie Wong‐Beringer. (2014). Patients presenting to the hospital with MRSA pneumonia: differentiating characteristics and outcomes with empiric treatment. BMC Infectious Diseases. 14(1). 252–252. 21 indexed citations

20.

Minejima, Emi, et al.. (2011). Applying New Diagnostic Criteria for Acute Kidney Injury To Facilitate Early Identification of Nephrotoxicity in Vancomycin-Treated Patients. Antimicrobial Agents and Chemotherapy. 55(7). 3278–3283. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact